Table 7.
Transition probabilities (in%) among features observed in Test Phase 1 in Cold group
| From feature to feature** | Cold group all values in% | |||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Start | Price | Brand | Side effect | Daily dose | Doctor’s advice | Availability | End | |
| Start | 0.00 | 1.05 | 3.68 | 41.05* | 7.37 | 41.05* | 5.79 | 0.00 |
| Price | 0.00 | 46.22* | 8.40 | 3.36 | 6.72 | 5.04 | 9.24 | 21.01 |
| Brand | 0.00 | 8.82 | 39.22* | 7.84 | 7.84 | 7.84 | 6.86 | 21.57 |
| Side effects | 0.00 | 4.38 | 4.06 | 40.00* | 14.69 | 15.94 | 3.75 | 17.19 |
| Daily dose | 0.00 | 8.37 | 4.65 | 12.09 | 39.53* | 12.56 | 12.09 | 10.70 |
| Doctor’s advice | 0.00 | 2.60 | 4.22 | 21.10 | 11.36 | 40.26* | 8.12 | 12.34 |
| Availability | 0.00 | 8.07 | 5.59 | 6.83 | 11.18 | 8.70 | 42.86* | 16.77 |
| End | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Notes:
*
Numbers in bold represent the% of the most clicked feature during the transition search process.
**
The search process is similar in both groups (please see also the Pain group) moving from “Side Effect”/Doctor’s advice (start) → Price → Brand → etc.. to the end) .